Table 1. Baseline Characteristics according to TCGA Clinical data about SARC (n=261).
| Characteristics | No. of patient (%) |
|---|---|
| Age (y) | |
| <60 | 116 (44.4) |
| ≥60 | 145 (55.6) |
| Gender | |
| Male | 119 (45.6) |
| Female | 142 (54.4) |
| Event | |
| Death | 99 (37.9) |
| Alive | 162 (62.1) |
| Overall survival | |
| ≥365 | 216 (82.8) |
| <365 | 45 (17.2) |
| Race | |
| White | 226 (86.6) |
| Asian | 6 (2.3) |
| Black or African American | 18 (6.9) |
| Not reported | 11 (4.2) |
| Histological type | |
| Dedifferentiated liposarcoma | 59 (22.6) |
| Desmoid tumor | 2 (0.8) |
| Leiomyosarcoma | 105 (40.2) |
| Malignant peripheral nerve sheath tumors | 9 (3.4) |
| Myxofibrosarcoma | 25 (9.6) |
| Synovial sarcoma | 10 (3.8) |
| Undifferentiated pleomorphic sarcoma | 51 (19.5) |
| Tumor site | |
| Chest | 13 (5.0) |
| Head and neck | 5 (1.9) |
| Lower abdominal/pelvic | 16 (6.1) |
| Lower extremity | 73 (28.0) |
| Not available | 1 (0.4) |
| Ovary | 1 (0.4) |
| Retroperitoneum/upper abdominal | 99 (37.9) |
| Superficial trunk | 12 (4.6) |
| Upper extremity | 12 (4.6) |
| Uterus | 29 (11.1) |